Investor Information
Latest News
-
Jefferies 2019 Global Healthcare Conference Presentation
June 4, 2019 | PDF Version
-
Indivior to present at Jeffries 2019 Healthcare Conference
May 16, 2019 | PDF Version
-
Indivior Enters into Exclusive License Agreement with HLS Therapeutics for PERSERIS™ (risperidone) in Canada
May 9, 2019 | PDF Version
-
2019 Annual General Meeting
May 8, 2019
Our Commitment
Updates on the Department of Justice Action
Get updates and information on Indivior’s ongoing response to the recent action by the U.S. Department of Justice and learn about the company’s unwavering commitment to patients, doctors, and communities fighting opioid addiction.
See more >
Upcoming Events
Webcasts/Audiocasts/Presentations
Click on the headings to view online or download a presentation:
RNS Filings
View Indivior filings with the Regulatory News Service on regulatory and non-regulatory updates.
